Roche Launches Algorithm Suite for Chronic Liver Disease Management
The panel integrates biomarker testing and digital tools to support fibrosis risk assessment and liver cancer surveillance.
Latest Articles
Editor's Top Picks
Experts Call for End to Routine ‘Corrected’ Calcium Reporting
A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
At-Home Finger Prick Blood Test May Screen for Dementia Risk
New research suggests that remote capillary sampling for Alzheimer’s biomarkers correlates with cognitive test performance in older adults.
Equipment & Supply Spotlight
Cenevo Adds Natural Language Search to Mosaic Lab Inventory Platform
Cenevo has introduced an AI-powered natural language search feature to its Mosaic lab inventory platform, enabling scientists to locate samples using plain language queries while maintaining data traceability.
News, Know-How & Standards
Disease Detection & Understanding
FDA Grants Breakthrough Designation to AI Bladder Cancer Prognostic Test
The FDA has granted Breakthrough Device Designation to Valar Labs’ Vesta Bladder Risk Stratify Dx, the first AI-powered digital pathology prognostic test for bladder cancer.
